Retour
6
Fourchette du Jour
6,11 €
6,30 €
Fourchette 52 Semaines
6,04 €
15,38 €
Volume
2 304 498
Moyenne 50J / 200J
7,73 €
/
9,93 €
Clôture Précédente
6,35 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -624,1 | 0,4 |
| P/B | 0,9 | 2,9 |
| ROE % | -0,2 | 3,7 |
| Net Margin % | -0,4 | 3,9 |
| Rev Growth 5Y % | 10,0 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
12,00 €
+92.0%
Low: 10,00 €
High: 16,00 €
P/E Prévisionnel
14,1
BPA Prévisionnel
0,45 €
Croissance BPA (est.)
+0,0%
CA Est.
430 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
0,66 €
0,65 € – 0,68 €
|
500 M | 1 |
| FY2028 |
0,56 €
0,16 € – 0,96 €
|
490 M | 2 |
| FY2027 |
0,50 €
0,48 € – 0,53 €
|
450 M | 7 |
Points Clés
Revenue grew 10,00% annually over 5 years — strong growth
Debt/Equity of 0,01 — conservative balance sheet
Generating 94,57M in free cash flow
Capital efficient — spends only 0,42% of revenue on capex
ROIC of 1,47% — low return on invested capital
Interest coverage of 1,06× — tight debt servicing
Croissance
Revenue Growth (5Y)
10,00%
Revenue (1Y)8,75%
Earnings (1Y)N/A
FCF Growth (3Y)8,06%
Qualité
Return on Equity
-0,15%
ROIC1,47%
Net Margin-0,38%
Op. Margin5,02%
Sécurité
Debt / Equity
0,01
Current Ratio2,05
Interest Coverage1,06
Valorisation
P/E Ratio
-624,11
P/B Ratio0,94
EV/EBITDA38,90
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,75% | Revenue Growth (3Y) | 8,72% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 10,00% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 418,84M | Net Income (TTM) | -1,60M |
| ROE | -0,15% | ROA | -0,10% |
| Gross Margin | 61,53% | Operating Margin | 5,02% |
| Net Margin | -0,38% | Free Cash Flow (TTM) | 94,57M |
| ROIC | 1,47% | FCF Growth (3Y) | 8,06% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 2,05 |
| Interest Coverage | 1,06 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -624,11 | P/B Ratio | 0,94 |
| P/S Ratio | 2,38 | PEG Ratio | 10,22 |
| EV/EBITDA | 38,90 | Dividend Yield | 0,00% |
| Market Cap | 995,46M | Enterprise Value | 817,47M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 418,84M | 385,15M | 354,34M | 335,64M | 286,10M |
| Net Income | -1,60M | -12,05M | -55,36M | 14,73M | -13,27M |
| EPS (Diluted) | -0,01 | -0,08 | -0,35 | 0,09 | -0,09 |
| Gross Profit | 257,71M | 230,63M | 213,32M | 203,07M | 174,49M |
| Operating Income | 21,02M | -1,73M | -40,77M | 32,52M | 13,58M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,56B | 1,58B | 1,56B | 1,57B | 1,51B |
| Total Liabilities | 493,79M | 516,45M | 516,30M | 493,26M | 469,88M |
| Shareholders' Equity | 1,06B | 1,06B | 1,05B | 1,08B | 1,04B |
| Total Debt | 11,40M | 311,90M | 302,57M | 308,13M | 308,38M |
| Cash & Equivalents | 189,39M | 179,18M | 234,95M | 236,59M | 185,80M |
| Current Assets | 315,12M | 310,85M | 340,20M | 342,25M | 274,73M |
| Current Liabilities | 153,39M | 146,09M | 130,02M | 103,16M | 92,23M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#812 of 825
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026